AGGF1 Gene - Angiogenic Factor

AGGF1 Gene - Angiogenic Factor

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">AGGF1 — Angiogenic Factor With G-Patch and FHA Domains 1</th>
</tr>
<tr> [@angiogenesis]
<td class="label">Symbol</td> [@bloodbrain]
<td><strong>AGGF1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Angiogenic Factor with G-Patch and FHA Domains 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>5q13.2</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/55109" target="_blank">55109</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100985" target="_blank">ENSG00000100985</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/609589" target="_blank">609589</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9Y5K8" target="_blank">Q9Y5K8</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Vascular Malformations](/diseases/vascular-malformations), [Moyamoya Disease](/diseases/moyamoya), [Stroke](/diseases/stroke)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Endothelial Cells, Brain, Heart, Lung</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">13 edges</a></td>
</tr>
</table>

AGGF1 — Angiogenic Factor With G-Patch and FHA Domains 1

Introduction

...

AGGF1 Gene - Angiogenic Factor

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">AGGF1 — Angiogenic Factor With G-Patch and FHA Domains 1</th>
</tr>
<tr> [@angiogenesis]
<td class="label">Symbol</td> [@bloodbrain]
<td><strong>AGGF1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Angiogenic Factor with G-Patch and FHA Domains 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>5q13.2</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/55109" target="_blank">55109</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100985" target="_blank">ENSG00000100985</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/609589" target="_blank">609589</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9Y5K8" target="_blank">Q9Y5K8</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Vascular Malformations](/diseases/vascular-malformations), [Moyamoya Disease](/diseases/moyamoya), [Stroke](/diseases/stroke)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Endothelial Cells, Brain, Heart, Lung</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">13 edges</a></td>
</tr>
</table>

AGGF1 — Angiogenic Factor With G-Patch and FHA Domains 1

Introduction

Aggf1 Gene Angiogenic Factor is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

AGGF1 encodes a protein with G-patch and FHA (forkhead-associated) domains that functions as an angiogenic factor. It plays important roles in vascular development and has been implicated in cerebrovascular disease and neurovascular function.

Function

AGGF1 has several important molecular functions:

Angiogenesis: Promotes the formation of new blood vessels

Vascular development: Essential for normal blood vessel formation

Cell proliferation: Supports endothelial cell growth

Signal transduction: G-patch domain suggests RNA-binding function

FHA domain: Involved in protein-protein interactions and signaling

Molecular Interactions

AGGF1 interacts with:

• VEGFA (Vascular Endothelial Growth Factor A)
• Angiopoietin pathway proteins
• RNA splicing machinery

Disease Associations

Vascular Malformations

AGGF1 mutations are associated with:

• Capillary malformations
• Arteriovenous malformations
• Glomuvenous malformations

Moyamoya Disease

Recent studies suggest AGGF1 variants may contribute to:

• Cerebrovascular occlusion
• Moyamoya angiopathy
• Intracranial hemorrhage risk

Stroke

Given its role in vascular health:

• May influence stroke susceptibility
• Affects cerebrovascular integrity
• Potential target for stroke prevention

Neurodegeneration

The vascular component of AGGF1 may be relevant to:

• Vascular dementia
• Cerebral amyloid angiopathy
• [Blood-brain barrier](/entities/blood-brain-barrier) function

Expression

AGGF1 is expressed in:

• Endothelial cells (high)
• Brain ([cortex](/brain-regions/cortex), hippocampus)
• Heart
• Lung
• Developing vasculature

Therapeutic Potential

AGGF1 represents a potential therapeutic target for:

• Promoting angiogenesis after stroke
• Treating vascular malformations
• Enhancing blood-brain barrier function

AGGF1 and the Neurovascular Unit

Components of the Neurovascular Unit

The [neurovascular unit](/mechanisms/neurovascular-unit) is a critical structure maintaining cerebral homeostasis:

Cellular Components

• Endothelial cells: Form the blood-brain barrier
• Pericytes: Regulate capillary blood flow
• Astrocytes: Perivascular end-feet ensheath vessels
• Neurons: Control vasodilation/vasoconstriction
• Microglia: Monitor vascular health

AGGF1's Role in Neurovascular Coupling

AGGF1 influences the coupling between neuronal activity and blood flow:

VEGF modulation: AGGF1 interacts with VEGFA signaling

Endothelial function: Supports endothelial cell viability

Angiogenic support: Promotes new vessel formation when needed

Barrier integrity: Contributes to BBB maintenance

Blood-Brain Barrier Function

AGGF1's role in [blood-brain barrier](/mechanisms/blood-brain-barrier) (BBB) integrity is particularly relevant to neurodegenerative diseases[@bloodbrain]:

BBB Components Maintained by AGGF1

| Component | AGGF1 Effect |
|-----------|---------------|
| Tight junctions | Supports expression of claudin-5, occludin |
| Transporters | Modulates BBB transporter function |
| Endothelial viability | Promotes endothelial cell survival |
| Pericyte coverage | Supports pericyte function |

BBB Dysfunction in Neurodegeneration

• Reduced AGGF1 may contribute to BBB breakdown
• Increased permeability allows neurotoxic molecules entry
• Impaired clearance of brain waste products
• Neuroinflammation from peripheral immune cell entry

AGGF1 in Specific Neurodegenerative Diseases

Alzheimer's Disease

Vascular dysfunction is increasingly recognized as a key component of AD pathogenesis:

The Vascular Hypothesis of AD

Cerebral hypoperfusion: Reduced blood flow precedes cognitive decline

BBB breakdown: Allows Aβ entry into brain

Impaired clearance: Reduced Aβ clearance across BBB

White matter damage: Ischemia leads to white matter lesions

AGGF1's Potential Role in AD

• AGGF1 expression may decline with age
• Reduced angiogenic support worsens hypoperfusion
• VEGF dysregulation affects Aβ clearance
• Therapeutic enhancement could restore vascular function

Vascular Dementia

AGGF1 is directly relevant to vascular cognitive impairment:

Mechanisms

• Chronic hypoperfusion: AGGF1 decline contributes to reduced perfusion
• Small vessel disease: Affects small vessel integrity
• White matter lesions: AGGF1 dysfunction may accelerate damage
• Stroke risk: AGGF1 variants affect stroke susceptibility

Therapeutic Implications

| Strategy | Rationale |
|----------|-----------|
| AGGF1 agonists | Enhance angiogenesis |
| VEGF modulation | Support vascular function |
| Gene therapy | AAV-mediated expression |

Parkinson's Disease

The [blood-brain barrier](/mechanisms/blood-brain-barrier) is also affected in PD:

• BBB breakdown in substantia nigra
• Reduced cerebral blood flow
• Vascular contributions to dopaminergic neuron loss
• AGGF1-based therapies may provide neuroprotection

Stroke

AGGF1 has particular relevance to stroke pathophysiology:

Post-Stroke Angiogenesis

• Critical for recovery
• New vessels support neuronal survival
• AGGF1 promotes revascularization
• Therapeutic enhancement improves outcomes

Ischemic vs. Hemorrhagic Stroke

| Type | AGGF1 Role |
|------|------------|
| Ischemic | Promotes post-ischemic angiogenesis |
| Hemorrhagic | May affect vascular stability |

Molecular Mechanisms

G-Patch Domain Function

The G-patch domain (glycine-rich RNA binding domain) suggests AGGF1 functions in RNA processing:

Predicted Functions

• RNA binding: May regulate splicing factors
• RNP complexes: Part of ribonucleoprotein particles
• Post-transcriptional regulation: Modulates mRNA stability
• Translation control: May affect protein synthesis

FHA Domain Function

The FHA (forkhead-associated) domain mediates protein-protein interactions:

Interaction Partners

• Kinases: Phosphothreonine/phosphotyrosine binding
• Transcription factors: Nuclear signaling
• Cell cycle proteins: Regulation of cell division
• DNA repair proteins: Genome maintenance

Signaling Pathways

AGGF1 influences multiple signaling pathways:

VEGF Signaling → PI3K/Akt → Endothelial survival
↓
ANG/Tie2 → MAPK/ERK → Angiogenesis
↓
FGF Signaling → Proliferation

Genetic Considerations

AGGF1 Variants

| Variant | Effect | Clinical Significance |
|---------|--------|----------------------|
| Loss-of-function | Reduced angiogenesis | Vascular malformation risk |
| Gain-of-function | Enhanced angiogenesis | Potential cancer applications |
| Common variants | Altered expression | Stroke risk modification |

Regulatory Polymorphisms

• Promoter variants: Affect expression levels
• 3' UTR variants: Modulate mRNA stability
• Splicing variants: Alter protein isoforms

Therapeutic Development

AGGF1-Based Therapies

| Approach | Stage | Indication |
|----------|-------|-----------|
| Recombinant AGGF1 | Research | Stroke recovery |
| Gene therapy | Preclinical | Chronic ischemia |
| Small molecule agonists | Discovery | Vascular dementia |

Delivery Challenges

• BBB penetration: Must cross blood-brain barrier
• Tissue targeting: Specific delivery to affected regions
• Dosing: Balancing angiogenic vs. vascular malformation risk
• Temporal control: Timing relative to disease progression

Biomarker Potential

AGGF1 as a Biomarker

| Marker | Utility | Sample Type |
|--------|---------|--------------|
| Plasma AGGF1 | Vascular function | Blood |
| CSF AGGF1 | CNS involvement | Cerebrospinal fluid |
| Expression in PBMCs | Disease activity | Blood |

Clinical Correlations

• AGGF1 levels correlate with vascular function markers
• May predict stroke risk
• Could monitor therapeutic response

Summary

AGGF1 represents a fascinating intersection of vascular biology and neurodegeneration. Its dual functionality—angiogenesis promotion through VEGF interaction and potential RNA processing via the G-patch domain—positions it as an important player in neurovascular health. The protein's involvement in blood-brain barrier maintenance, cerebral angiogenesis, and vascular malformation pathogenesis makes it a relevant therapeutic target for conditions ranging from stroke to Alzheimer's disease. Understanding AGGF1's full range of functions in the central nervous system and developing targeted therapeutic interventions hold promise for addressing the vascular components of neurodegenerative diseases.

See Also

• [Moyamoya Disease](/diseases/moyamoya-disease)
• [Vascular Dementia](/diseases/vascular-dementia)
• [Angiogenesis](/mechanisms/angiogenesis)
• [Blood-Brain Barrier](/mechanisms/blood-brain-barrier)
• [VEGF Signaling](/mechanisms/vegf-signaling)

Background

The study of Aggf1 Gene Angiogenic Factor has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

[Unknown, AGGF1 and angiogenesis (n.d.)](https://pubmed.ncbi.nlm.nih.gov/15536087/)

[Unknown, AGGF1 mutations in vascular malformations (n.d.)](https://pubmed.ncbi.nlm.nih.gov/20459757/)

[Unknown, AGGF1 in cerebrovascular disease (n.d.)](https://pubmed.ncbi.nlm.nih.gov/22326551/)

[Unknown, G-patch domain proteins in RNA processing (n.d.)](https://pubmed.ncbi.nlm.nih.gov/18660847/)

[Unknown, Angiogenesis in neurological disease (n.d.)](https://pubmed.ncbi.nlm.nih.gov/19796954/)

[Unknown, Blood-brain barrier and neurodegeneration (n.d.)](https://pubmed.ncbi.nlm.nih.gov/24239741/)